Annual CFO
-$765.27 M
+$78.13 M+9.26%
31 March 2024
Summary:
Roivant Sciences annual cash flow from operations is currently -$765.27 million, with the most recent change of +$78.13 million (+9.26%) on 31 March 2024. During the last 3 years, it has fallen by -$213.13 million (-38.60%). ROIV annual CFO is now -38.60% below its all-time high of -$552.14 million, reached on 31 March 2021.ROIV Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$266.81 M
-$73.98 M-38.36%
30 September 2024
Summary:
Roivant Sciences quarterly cash flow from operations is currently -$266.81 million, with the most recent change of -$73.98 million (-38.36%) on 30 September 2024. Over the past year, it has dropped by -$70.38 million (-35.83%). ROIV quarterly CFO is now -172.13% below its all-time high of -$98.05 million, reached on 30 September 2020.ROIV Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$778.54 M
-$70.38 M-9.94%
30 September 2024
Summary:
Roivant Sciences TTM cash flow from operations is currently -$778.54 million, with the most recent change of -$70.38 million (-9.94%) on 30 September 2024. Over the past year, it has increased by +$69.50 million (+8.19%). ROIV TTM CFO is now -600.34% below its all-time high of -$111.17 million, reached on 01 June 2020.ROIV TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ROIV Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.3% | -35.8% | +8.2% |
| 3 y3 years | -38.6% | -121.2% | -28.8% |
| 5 y5 years | - | - | - |
ROIV Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -38.6% | +9.3% | -146.0% | +0.6% | -28.8% | +9.2% |
| 5 y | 5 years | -38.6% | +9.3% | -172.1% | +0.6% | -600.3% | +9.2% |
| alltime | all time | -38.6% | +9.3% | -172.1% | +0.6% | -600.3% | +9.2% |
Roivant Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$266.81 M(+38.4%) | -$778.54 M(+9.9%) |
| June 2024 | - | -$192.83 M(+77.8%) | -$708.16 M(-7.5%) |
| Mar 2024 | -$765.27 M(-9.3%) | -$108.46 M(-48.5%) | -$765.27 M(-8.4%) |
| Dec 2023 | - | -$210.45 M(+7.1%) | -$835.90 M(-1.4%) |
| Sept 2023 | - | -$196.43 M(-21.4%) | -$848.04 M(+0.8%) |
| June 2023 | - | -$249.93 M(+39.6%) | -$841.24 M(-0.3%) |
| Mar 2023 | -$843.39 M | -$179.09 M(-19.5%) | -$843.39 M(+3.9%) |
| Dec 2022 | - | -$222.59 M(+17.4%) | -$811.77 M(-5.4%) |
| Sept 2022 | - | -$189.63 M(-24.8%) | -$857.67 M(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$252.08 M(+70.9%) | -$788.64 M(+16.4%) |
| Mar 2022 | -$677.73 M(+22.7%) | -$147.47 M(-45.1%) | -$677.73 M(+6.5%) |
| Dec 2021 | - | -$268.49 M(+122.6%) | -$636.33 M(+5.2%) |
| Sept 2021 | - | -$120.60 M(-14.6%) | -$604.69 M(+3.9%) |
| June 2021 | - | -$141.17 M(+33.1%) | -$582.14 M(+5.4%) |
| Mar 2021 | -$552.14 M | -$106.07 M(-55.2%) | -$552.14 M(+23.8%) |
| Dec 2020 | - | -$236.86 M(+141.6%) | -$446.07 M(+113.2%) |
| Sept 2020 | - | -$98.05 M(-11.8%) | -$209.21 M(+88.2%) |
| June 2020 | - | -$111.17 M | -$111.17 M |
FAQ
- What is Roivant Sciences annual cash flow from operations?
- What is the all time high annual CFO for Roivant Sciences?
- What is Roivant Sciences annual CFO year-on-year change?
- What is Roivant Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Roivant Sciences?
- What is Roivant Sciences quarterly CFO year-on-year change?
- What is Roivant Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Roivant Sciences?
- What is Roivant Sciences TTM CFO year-on-year change?
What is Roivant Sciences annual cash flow from operations?
The current annual CFO of ROIV is -$765.27 M
What is the all time high annual CFO for Roivant Sciences?
Roivant Sciences all-time high annual cash flow from operations is -$552.14 M
What is Roivant Sciences annual CFO year-on-year change?
Over the past year, ROIV annual cash flow from operations has changed by +$78.13 M (+9.26%)
What is Roivant Sciences quarterly cash flow from operations?
The current quarterly CFO of ROIV is -$266.81 M
What is the all time high quarterly CFO for Roivant Sciences?
Roivant Sciences all-time high quarterly cash flow from operations is -$98.05 M
What is Roivant Sciences quarterly CFO year-on-year change?
Over the past year, ROIV quarterly cash flow from operations has changed by -$70.38 M (-35.83%)
What is Roivant Sciences TTM cash flow from operations?
The current TTM CFO of ROIV is -$778.54 M
What is the all time high TTM CFO for Roivant Sciences?
Roivant Sciences all-time high TTM cash flow from operations is -$111.17 M
What is Roivant Sciences TTM CFO year-on-year change?
Over the past year, ROIV TTM cash flow from operations has changed by +$69.50 M (+8.19%)